Interventions to reduce experiences of stigma and discrimination of people with mental illness and their caregivers

Buechter, Roland Brian; Pieper, Dawid; Ueffing, Erin; Zschorlich, Beate

doi:10.1002/14651858.cd010400

Cited by 9 publications

(5 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A mental illness stigma intervention protocol 64 suggests anti-stigma interventions should examine the effect on stigma and discrimination of people with mental illness as well as their caregivers. A similar research protocol would be applicable for research on stigma among people with epilepsy.…”

Section: Discussionmentioning

confidence: 99%

Epilepsy misconceptions and stigma reduction: Current status in Western countries

Herrmann

Welter

Berg

et al. 2016

Epilepsy & Behavior

View full text Add to dashboard Cite

Objective: This systematized literature review identified reports describing epilepsy misconceptions in the developed Western countries and research interventions focused on reducing these misconceptions. Materials and Methods: English language publications from January 2004 to January 2015 that described original research conducted in Europe, North/Central/South America or Australia on misconceptions about epilepsy among the general public. Results: 81 publications were selected. Most studies were conducted in the Americas (N=30) and Europe (N=31). Misconceptions and attitudes about epilepsy were assessed among clinical providers (N= 9), family members of people with epilepsy (PWE, N=5), teachers (N= 11), students (N=22), and the general public (N= 25). Most studies used structured questionnaires, sometimes adding open-ended questions. Misconceptions reflected socially exclusionary attitudes directed at PWE, ignorance about treatment, and over-generalizations that are stigmatizing when applied to all PWE. Misconceptions were more prevalent in those with less education, lower socioeconomic status, and no exposure to PWE. There were only 12 intervention studies. While intervention studies were generally effective in improving attitudes, many were targeted to healthcare and education settings, were time intensive, and impractical for broad general population implementation. None incorporated newer technology-based strategies regarding effective health communication approaches. Conclusions: Types of epilepsy misconceptions were similar in reports published over the last decade, although most referred to misconceptions that have already been previously described. Existing questionnaires may fail to identify more subtle forms of current misconceptions and negative attitudes. Few interventional studies specifically target epilepsy stigma. Practical and broad scalable approaches to de-stigmatize epilepsy may help reduce misconceptions.

show abstract

Section: Discussionmentioning

confidence: 99%

Epilepsy misconceptions and stigma reduction: Current status in Western countries

Herrmann

Welter

Berg

et al. 2016

Epilepsy & Behavior

View full text Add to dashboard Cite

show abstract

“…Stigma reduction programmes targeted at the potential adopters (as well as the general community, see Sect. 8.3) may be required [174–176]. The universal supply of naloxone to all with a risk of opioid overdose as part of standard care (and with a patient ‘opt out’ model [177]) has been proposed to address stigma, and also address clinicians’ duty of care where overdose risk is identified.…”

Section: Barriers To Wider Implementationmentioning

confidence: 99%

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

Strang

McDonald

Campbell

et al. 2019

Drugs

View full text Add to dashboard Cite

Naloxone is a well-established essential medicine for the treatment of life-threatening heroin/opioid overdose in emergency medicine. Over two decades, the concept of ‘take-home naloxone’ has evolved, comprising pre-provision of an emergency supply to laypersons likely to witness an opioid overdose (e.g. peers and family members of people who use opioids as well as non-medical personnel), with the recommendation to administer the naloxone to the overdose victim as interim care while awaiting an ambulance. There is an urgent need for more widespread naloxone access considering the growing problem of opioid overdose deaths, accounting for more than 100,000 deaths worldwide annually. Rises in mortality are particularly sharp in North America, where the ongoing prescription opioid problem is now overlaid with a rapid growth in overdose deaths from heroin and illicit fentanyl. Using opioids alone is dangerous, and the mortality risk is clustered at certain times and contexts, including on prison release and discharge from hospital and residential care. The provision of take-home naloxone has required the introduction of new legislation and new naloxone products. These include pre-filled syringes and auto-injectors and, crucially, new concentrated nasal sprays (four formulations recently approved in different countries) with speed of onset comparable to intramuscular naloxone and relative bioavailability of approximately 40–50%. Choosing the right naloxone dose in the fentanyl era is a matter of ongoing debate, but the safety margin of the approved nasal sprays is superior to improvised nasal kits. New legislation in different countries permits over-the-counter sales or other prescription-free methods of provision. However, access remains uneven with take-home naloxone still not provided in many countries and communities, and with ongoing barriers contributing to implementation inertia. Take-home naloxone is an important component of the response to the global overdose problem, but greater commitment to implementation will be essential, alongside improved affordable products, if a greater impact is to be achieved.

show abstract

“…Similarly, research has shown that health professionals’ positive attitudes are enhanced when they have more than a month of experience providing psychiatric services (Hsiao et al, 2015 ). Understanding the beliefs and attitudes of medical students towards these users at an early stage is crucial for identifying potential negative perceptions and implementing appropriate measures to alleviate the stigmatization experienced by this group and its subsequent effects on the health care user population (Buechter et al, 2013 ).The international body of evidence indicates that healthcare students hold diverse perspectives regarding individuals with mental illness, which have a direct bearing on the quality of care and attention provided to those afflicted with such conditions (Stefanovics et al, 2016 ). This is crucial, as these attitudes have direct effects on the mental health of those affected, which can result in severe consequences like suicide (Campo-Arias & Herazo, 2015 ).…”

Section: Discussionmentioning

confidence: 99%

Exploring mental health stigma among Indonesian healthcare students towards individuals with mental illnesses: a qualitative study

Subu,

Dias,

Mottershead

et al. 2024

International Journal of Qualitative Studies on Health and Well

View full text Add to dashboard Cite

Background The social disapproval or stigma surrounding mental illness contributes to the postponement of individuals seeking assistance and frequently undermines therapeutic alliances between mental illness sufferers and health care professionals. Aims This study explored perceptions and attitudes towards individuals with mental illness among college healthcare students in Indonesia. Methods This study used a qualitative method. Twenty five students enrolled in six healthcare programs were interviewed using a semi structured format. The data analysis adopted a thematic analysis. Results Our thematic analysis generated four main themes: (1) general perceptions of mental health and mental illness; (2) knowledge about mental illness; (3) mental health stigma; and (4) mental health stigma campaigns. Conclusions The participants exhibited positive perceptions of mentally ill people. Students understood mental health, and they exhibited positive attitudes toward mentally ill people. Some students have stigma and lack of confidence to assist those who have mental illness. Further efforts are required to acquaint students with mental health issues and facilitate their interaction with mentally ill individuals. Anti-stigma campaigns are required to combat the pervasive stigmatization of individuals with mental illness. It is recommended to conduct a more extensive study about the stigma that students encounter in relation to mentally ill individuals.

show abstract

Interventions to reduce experiences of stigma and discrimination of people with mental illness and their caregivers

Cited by 9 publications

References 63 publications

Epilepsy misconceptions and stigma reduction: Current status in Western countries

Epilepsy misconceptions and stigma reduction: Current status in Western countries

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

Exploring mental health stigma among Indonesian healthcare students towards individuals with mental illnesses: a qualitative study

Contact Info

Product

Resources

About